\ New diabetes clinical trial: A Phase 3 Randomized, Controlled Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual β-cell Function - Bestiny

Translate

Friday, 13 November 2020

Clinical Trials diabetes Health New diabetes clinical trial: A Phase 3 Randomized, Controlled Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual β-cell Function

New diabetes clinical trial: A Phase 3 Randomized, Controlled Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual β-cell Function

by on in , ,
Published on: November 13, 2020 at 10:30PM
Condition:   New-onset type1 Diabetes
Interventions:   Drug: Ladarixin;   Drug: Placebo
Sponsor:   Dompé Farmaceutici S.p.A
Not yet recruiting
https://ift.tt/36wU0XJ
By on
Labels: , ,

No comments:

Post a Comment

Nothing happens without a Reason
Make Something out of it.

Subscribe to: Post Comments (Atom)